Skip to main content
. 2023 Nov 8;623(7988):803–813. doi: 10.1038/s41586-023-06717-x

Extended Data Fig. 3. Functional testing of NFKB2 variants by overexpression.

Extended Data Fig. 3

(a) Schematic representation of the alternative NF-κB pathway and the function of the p52/RelB and p52/p52 heterodimers (left panel); a graphical overview of the luciferase assay for testing the p52 function of the NFKB2 variants (middle panel); and a schematic representation of the functional consequences of the WT, p52GOF and p52LOF variants in the luciferase assay (right panel). (b) Relative luciferase activity (RLA) of WT or RelA-deficient HEK293T cells transfected with a κB reporter construct (κB-luc) in the absence or presence of plasmids encoding NIK and/or RelB for 24, 48 or 72 h. Results are expressed as the RLA normalized against the value for the EV. Bars represent the mean values (± s.d.) from 3 independent experiments performed in technical duplicates. (c) Western blot of HEK293T cells transfected for 24 h (left panel) or 48 h (right panel) in the absence or presence of plasmids encoding NIK and the WT or previously reported biochemical NF- κB2/p100 mutants. Data representative of two independent experiment are shown. (d) Luciferase assay testing the NF-κB2/p100 biochemical mutants (left) or deleterious variants from patients (right), 24 h after transfection. Bars represent the mean values (± s.d.) from more than 3 independent experiments.